Calyxo
PrivateLast Round
Series F
Apr 14, 2026
Total Funding Raised
$137.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Calyxo is a medical device company that develops a vacuum-assisted retrieval device for the efficient removal of kidney stone fragments, allowing for the extraction of multiple fragments in a single insertion and achieving exceptional stone-free results in a streamlined procedure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calyxo Comparables
Compare Calyxo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 80% | |
| Well Lead Med Co Ltd | 77% | |
| Olympus | 75% |
Calyxo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Apr 14, 2026 | ||||
| Series D | Dec 12, 2023 | ||||
| Series C | Jul 6, 2022 | ||||
| Series B | Oct 15, 2019 | ||||
| Series A | Aug 16, 2018 | ||||
Seed | Mar 29, 2016 |
Calyxo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series F |
| Ally Bridge Group | Series F |
| Questa Capital | Series D, Series B, Series F, Series C |
| Avidity Partners Management | Series D |
| Avidity Partners | Series D |
| CRG | Series D, Series F, Series C |
| VIC Technology Venture Development | Series A, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 132% MoM, reaching 3.7K.
- Jul 21, 2026
Grew 17% QoQ, from 325 to 380 employees.
Calyxo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Calyxo's valuation, stock price, and market status.
Is Calyxo a public or private company?
Calyxo is a private company.
What is the current stock price of Calyxo?
Calyxo is a private company with no public stock price. No recent secondary market data is available.
How much is Calyxo worth (valuation)?
Valuation information for Calyxo is not publicly available.
Can I buy Calyxo stock?
Calyxo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Calyxo's last funding round?
Calyxo's most recent funding round was Series F on April 14, 2026.
Who are the main investors in Calyxo?
Key investors in Calyxo include Janus Henderson Group, Ally Bridge Group, Questa Capital, Avidity Partners, CRG.
Will Calyxo IPO soon?
No public IPO plans have been announced for Calyxo.
How can I track Calyxo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Calyxo's secondary market activity and sign up for updates.